Stockwell Lynn

Stockwell Lynn is listed in filings as CEO and Exe. Chair of Board at Drugs Made In America Acquisition Corp. Units. This profile follows SEC Form 4 activity through Feb 18, 2025, including purchase activity and sale activity. Recent filings connect the profile to Drugs Made In America Acquisition Corp. Units (DMAAU). The current snapshot covers public activity from Feb 4, 2025 to Feb 18, 2025. Reported amounts are shown as $8.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.